The direct aspiration first pass technique (ADAPT) is a recent endovascular treatment for ischemic stroke due to large vessel occlusion that has been gaining popularity due to the rapidity of the technique and the potential for cost savings in comparison to standard thrombectomy methods such as stent retrievers. However, few studies have directly compared these 2. OBJECTIVE: To compare ADAPT with stent retrievers for thrombectomy via systematic review and meta-analysis. METHODS: Ovid Medline, PubMed, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, ACP Journal Club, and Database of Abstracts of Review of Effectiveness limited to English through September 2016 were systematically searched. Eligible studies included those in which patient cohorts underwent ADAPT for acute stroke. Recanalization efficiency, clinical outcomes, and complication rates of ADAPT were compared with the current standard of endovascular thrombectomy techniques. RESULTS: Seventeen studies on ADAPT and 5 randomized controlled trials on endovascular therapy were included. ADAPT achieved higher rates of complete revascularisation (89.4% vs 71.7%, P < .001) but similar clinical outcomes compared to front-line endovascular therapy. Seventy-one point four percent of ADAPT cases were successfully recanalized with aspiration alone, and a trend towards reduced time from groin puncture to recanalization time was noted (44.77 vs 61.46 min, P = .088).
S
troke remains a leading cause for morbidity and mortality 1 accounting for over 130 000 deaths in the United States and healthcare costs reaching $40 billion annually. 1, 2 In recent randomized controlled ABBREVIATIONS: ADAPT, a direct aspiration first pass technique; CI, confidence interval; mRS, modified Rankin Scale; MOOSE, Meta-analysis Of Observational Studies in Epidemiology group; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hemorrhage; SRLA, stent retriever with local aspiration; TPA, tissue plasmogen activator trials, endovascular therapy has been shown to be superior to medical therapy for the treatment of acute ischemic stroke from large vessel occlusion. [3] [4] [5] [6] [7] Success of these trials has been attributed to the use of improved prerandomization imaging protocols 8, 9 and the use of stent retrievers, which addressed the limitations of thrombectomy devices used in earlier trials.
Stent retrievers can be combined with largebore aspiration catheters, referred to as the "Solumbra" technique, where the stent retriever is removed under concurrent aspiration to minimize clot fragmentation and potential distal vessel occlusion. Although aspiration alone has been attempted for thrombectomy, the technique was limited largely by the technology, with catheters that were either not large enough to provide adequate force for aspiration thrombectomy or too inflexible to navigate the tortuous cerebral vasculature.
Recent technological advances include the development of large-bore aspiration thrombectomy catheters that are more maneuverable. This has led to the development of the direct aspiration first pass technique (ADAPT). This technique involves the use of new-generation catheters to remove the thrombus with aspiration alone first. In traditional ADAPT technique, aspiration is attempted for 20 s. Should this fail, the large aspiration catheter is repositioned and another attempt is made. If this is not successful, the large-bore aspiration catheter can then act as a conduit to pass a stent retriever subsequently at the discretion of the interventionalist. The ADAPT approach has gained increasingly popularity, due to the rapidity of the technique and the potential for cost savings, and a recent survey has reported this technique to be the most commonly used approach in the United States. 10 However, few studies have directly compared ADAPT with stent retrievers for thrombectomy.
Therefore, we aimed to compare the recanalization efficiency, clinical outcome, and complication rate of ADAPT with the current standard of endovascular thrombectomy techniques, via a meta-analysis of pooled ADAPT data vs pooled endovascular therapy data from recently published randomized controlled trials.
METHODS

Information Sources and Search Strategy
For this systematic review and meta-analysis, we followed recommended guidelines including those of PRISMA. [11] [12] [13] We searched a number of electronically available data sources and databases including Medline (Ovid), PubMed, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, ACP Journal Club, and Database of Abstracts of Review of Effectiveness from their dates of inception to September 2016. Our search strategy involved combinations of the terms: "direct aspiration," "first-pass," "ADAPT," "stent retriever," "stroke," as either key words or MeSH terms. The reference lists of all selected articles were also thoroughly searched to see if there were articles that could be included in the present systematic review and meta-analysis.
Study Selection
Our inclusion criteria were such that only articles in which patient cohorts underwent ADAPT therapy for acute stroke therapy were eligible for qualitative and quantitative analysis. Randomized controlled trials comparing contemporary endovascular therapy techniques vs medical therapy for acute stroke were also included for comparison with pooled ADAPT outcomes data. In situations of 1 cohort analyzed with followup data in a number of publications, we chose to include the most recent or complete publication for assessment in our meta-analysis. Studies that reported outcomes of cadaveric or animal studies, or those that were published in a language other than English, were excluded from the present analysis. Abstracts, case studies, presentations, opinion or editorial letters, reviews, and expert opinions were excluded.
Data Extraction and Critical Appraisal
Two reviewers (K.P., I.T.) independently reviewed each retrieved article, and extracted data from the text, tables, or figures where appropriate, via a standardized computerized spreadsheet. Baseline characteristics extracted include age, proportion of males, baseline intravenous tissue plasmogen activator (IV TPA) use, baseline National Institute of Health Stroke Scale (NIHSS), and NIHSS at discharge. Periprocedural parameters included event onset to groin puncture time, groin puncture to reperfusion time, and aspiration alone success rate. Primary functional outcome was 90-d modified Rankin Scale (mRS) score 0 to 2 and secondary outcomes included 90-d mRS 0 to 1 for excellent outcome. Complications extracted include symptomatic intracerebral hemorrhage (sICH) and mortality rates.
Differences or disagreements between the 2 reviewers were resolved by discussion and consensus. If the study did not provide means and standard deviations, we estimated these parameters from the median and range values by methods described by Hozo et al. 14 Because quality scoring is controversial in meta-analyses of observational studies, 2 reviewers independently appraised each article included in our analysis according to the critical review checklist of the Dutch Cochrane Centre proposed by the Meta-analysis Of Observational Studies in Epidemiology group (MOOSE).
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Statistical Analysis
A meta-analysis of proportions was conducted for the primary and secondary outcomes of this study. We anticipated heterogeneity and hence proportions were combined using DerSimonian-Laird random effects models. 16 As previously described, heterogeneity was evaluated using Cochran Q and I 2 test. 17, 18 A formal comparison was performed between outcomes for the ADAPT technique and standard endovascular therapy in terms of baseline, periprocedural, and functional outcomes and complications using mixed-effects meta-regression with a moderator variable for technique (ADAPT vs standard thrombectomy approach). All analyses were performed using the metafor package for R version 3.01.
19 P values <.05 were considered statistically significant.
RESULTS
Search Strategy
A total of 906 studies were identified from the electronic databases and reference lists searches. After exclusion of duplicate or irrelevant references, 94 relevant articles were retrieved. After detailed evaluation of these articles, 23 studies remained for assessment, including 17 studies 8,10,20-34 on the ADAPT technique and 5 randomized controlled trials [3] [4] [5] [6] [7] on endovascular therapy for acute stroke therapy (Figure 1 ; Table) . The randomized trials included were ESCAPE, 3 EXTEND, 5 MR CLEAN, 6 REVASCAT, 7 and SWIFT PRIME. 4 
Baseline Characteristics
Overall, the average age of the ADAPT cohort was 68.8 (95% confidence interval [CI]: 67.07-70.63). This was compared to the average age of the thrombectomy cohort, which was 67.1 (95% CI: 64.7-69.5) yr. There was no significant difference between the groups (P = .32). The proportion of males in the ADAPT group was 52.3% compared to 55.4% in the thrombectomy cohort, and this was not significantly different (P = .37). Baseline IV TPA use for the ADAPT cohort was significantly lower compared to the thrombectomy cohort (52.8% vs 85.9%, P < .001). In terms of baseline NIHSS, this was comparable between ADAPT and thrombectomy cohorts (15.77 vs 16.7, P = .35). Similarly, NIHSS at discharge was also comparable between ADAPT and thrombectomy cohorts (5.56 vs 6.94, P = .51).
Event Onset to Groin Puncture Rime and Groin Puncture to Reperfusion Time
There was a trend for time of onset to groin puncture to be longer for ADAPT vs thrombectomy cohorts (300.35 vs 229.71 min, P = .196), but this did not reach statistical significance. Time of groin puncture to recanalization was trending towards being lower for the ADAPT cohort compared to thrombectomy, but did not reach statistical significance (44.77 vs 61.46 min, P = .088).
Aspiration Alone Success Rate
First-pass aspiration success rate was reported in 13 of the included ADAPT studies. The pooled success rate was 71.4% (95% CI: 64.9-77.8), with significant heterogeneity detected (I 2 = 83%, P < .001).
Weighted pooled estimates for successful recanalization (TICI 2b-3) was found to be 89.6% (95% CI: 85.6-93.6, I 2 = 87.8%) in the ADAPT cohort, compared to 71.7% (95% CI: 62.0-81.4%, I 2 = 83.96%) for the thrombectomy cohort. Successful recanalization was significantly higher for the ADAPT technique (P < .001; Figure 2 ).
Functional Outcomes
The primary outcome of the present review was the 90-d mRS 0 to 2 for functional outcome. Meta-analysis demonstrated that the pooled proportion of patients with mRS 0 to 2 was 52.3% (95% CI: 46.1-58.6, I 2 = 73.3%). This was compared to thrombectomy cohort with pooled mRS 0 to 2 proportion of 51.3% (95% CI: 38.5-64.1, I 2 = 90.4%). No significant difference was found between ADAPT and thrombectomy for mRS 0 to 2 (P = .826; Figure 3 ).
Secondary outcomes analysis included 90-d mRS 0 to 1 for excellent outcome. Pooled proportion of ADAPT patients who had mRS 0 to 1 was 45.9% (95% CI: 34-57.8, I 2 = 77.5%), compared to thrombectomy of 32.3% (95% CI: 18.1-46.6, I 2 = 93.9%). There was a trend towards higher proportion of patients with mRS 0 to 1 in the ADAPT group compared with thrombectomy (P = .11). 
Symptomatic Intracerebral Hemorrhage
The proportion of patients with sICH in the ADAPT group was 6.7% (95% CI: 3.6-9.8, I 2 = 82.3%) compared to thrombectomy group with 2.9% (95% CI: 0.4-0.5, I 2 = 75.6%). This was not found to be significantly different (P = .14; Figure 4 ).
Mortality
The pooled mortality rate in the ADAPT cohort was 12.5% (95% CI: 8.3-16.7, I 2 = 79.6%). This is compared to the thrombectomy group with pooled mortality of 13.7% (95% CI: 8.9-18.6, I 2 = 76.2%). There was no significant difference detected (P = .73; Figure 5 ). 
DISCUSSION
The treatment of acute ischemic stroke has been revolutionized by the advent and development of mechanical thrombectomy technologies. However, results of the current and recent randomized evidence show that despite favorable outcomes compared to intra-arterial fibrinolysis or Merci device thrombectomy, 35, 36 the rate of revascularization failure still remains suboptimal. 37, 38 It has been established that the positive effect of thrombectomy is time dependent with a greater likelihood of achieving a favorable outcome in patients who have early recanalization. 6, 39, 40 As such, there is continued interest in the development of thrombectomy technologies and alternative strategies, which may offer more rapid, cheaper, and better recanalization rates and hence favorable outcomes. Most thrombectomy procedures in these trials were performed using stent retriever technology, which many consider the gold standard for thrombectomy. Alternative techniques include the use of large-bore aspiration catheters, which previously required adjunctive technologies such as stent retriever to augment aspiration or using aspiration as a second-line approach if stent retrieval fails. 41, 42 One such alternative technique is the use of the aspirationalone strategy as first pass. Historically, this technique was not feasible due to the limitations in the available catheter technology. Early catheters that were large enough to generate the required force for aspiration of the thrombus were too inflexible to navigate the difficult cerebrovascular anatomy. Conversely, small-sized flexible catheters suitable for navigating the anatomy did not provide sufficient suction force for aspiration of the thrombus. However, the latest generation of tractable large-bore aspiration catheters allows both adequate aspiration force in most cases as well as the necessary maneuverability to navigating the cerebral vasculature.
In the present study, we found that the use of first-pass aspiration approach or ADAPT achieved higher rate of complete revascularisation compared to front-line endovascular therapy or stent retriever strategy. Seventy-one point four percent of ADAPT cases were successfully recanalized with aspiration alone, without requiring adjunct retriever deployment, and while a trend towards reduced time from groin puncture to recanalization time was noted, this was not significant. While the rate of recanalization was higher for ADAPT, the clinical outcomes were similar between the 2 approaches. There was a trend towards a greater proportion of patients who had excellent functional outcomes in the ADAPT group compared to standard endovascular therapy. Given the comparable results of the pooled ADAPT studies with the recent randomized studies, these findings are encouraging, but must be interpreted with caution. In many firstgeneration studies, endovascular therapy was pooled such that there were unknown quantities of patients who underwent failed aspiration and went on to mechanical thrombectomy and possibly vice-versa. We exclude the possibility of such a confounding factor by only comparing ADAPT data to that of ESCAPE, EXTEND, MR CLEAN, REVASCAT, and SWIFT PRIME.
The results of the present study are similar to that of Turk et al, 42 who first reported and published on the ADAPT technique with the latest generation tractable catheters. In their study of 222 patients who underwent mechanical thrombectomy, they compared 64 ADAPT cases, 128 traditional Penumbra system (Penumbra Inc, Alameda, California) cases, and 30 cases of stent retriever with local aspiration (SRLA). Similarly, to the present pooled results, they reported 95% cases TICI 2b-3 with ADAPT, compared to 83% with SRLA and 79% with the Penumbra system with separator in any size and combination. Average time to recanalization for ADAPT was 37 min, comparable to the pooled time for the present meta-analysis. This was found to be significantly shorter compared to SRLA (47 min) and the traditional Penumbra system (88 min). Their cost analysis also demonstrated significantly lower costs for ADAPT ($33 611) compared to SRLA ($54 700) and Penumbra ($51 599), the difference being driven by lower procedure costs, lower hospitalization costs, and reduced length of stay. The higher costs associated with stent retrievers may be due to the use of the device itself, as well as the risk of fragmentation and dislodging thrombus debris further downstream, which necessitates further thrombectomy and thus further costs. As such, the authors concluded that the ADAPT technique is efficacious and cost-effective for revascularization of large vessel intracranial occlusions.
The crux of the ADAPT technique is its philosophy in starting with a simple step of aspiration with an atraumatic and easily tractable catheter. This method can then be stepped up to more complex use of stent retrievers if the first-step aspiration was not successful. 32, 42 For the majority of thrombi successfully extracted via aspiration alone, the risk of perforation of intracranial vessels was reduced, as there is no procedure performed through the clot per se. 43 As such, the ADAPT technique may be suitable for occlusions in locations such as the basilar apex, which is typically susceptible to hemorrhagic complications due to small arteries which can be perforated nearby. A distinct benefit of using the ADAPT technique as the firstline treatment for the thrombectomy is that it can be performed quickly and at a lower cost, as not all procedures will require stent retriever deployment. Our present study demonstrated a trend towards reduced groin puncture to canalization time, which could translate into improved outcomes. 6, 39 The procedure can be performed quickly, and as such Turk et al 21, 22 have routinely not placed bladder catheters or arterial lines prior to the procedure unless easily obtained, thus further expediting the procedure. Although a formal economic comparison between the ADAPT and standard endovascular approaches have not been performed in our current study, the high aspiration-alone success rate of the ADAPT strategy without the requirement for further retriever deployment strongly suggests that the ADAPT strategy may be economically advantageous. However, if aspiration does not provide adequate recanalization and a stent retriever is required, this may in fact delay reperfusion of the brain. As such, it is important to understand the possible factors that contribute to aspiration failure.
Prior studies have suggested several factors that could influence the success of endovascular procedures for acute ischemic stroke. There is currently very limited evidence evaluating the role of vascular anatomy on the outcomes of the ADAPT strategy. In 1 study by Mascitelli et al, 27 the authors found that the number of reverse curves, a marker of difficult vascular anatomy, correlated with aspiration failure. This is likely secondary to difficulty in navigating a large-bore catheter through these curves to access the thrombus. This can potentially lead to longer groin to recanalization times, and may be reflected in poorer neurological outcomes. Another factor that could influence the aspiration success of the ADAPT technique includes clot composition data. Histological studies have shown conflicting evidence regarding the composition of cardioembolic clots compared to atherosclerotic clots, and it is unclear how this affects clinical outcomes. 44, 45 Regarding the immunohistological analysis of clot, it was found that red blood cells predominated clot composition in embolus vs thrombus. 46 This is why the cardioembolic clot imparts the so-called "susceptibility vessel sign." 47 Conversely, thrombus is composed mostly of fibrin (whereas an embolus contains a greater amount of both red and white blood cells). If the percentage of white blood cells is higher, outcome is seemingly worse. 44 This is why studies have also shown that a greater percentage of red blood cells is correlated with better outcomes. Further research in this area is required. As such, this is another factor that has not been accounted for in the present study.
Limitations
The present study is constrained by several limitations. Firstly, most ADAPT studies had small sample sizes and were retrospective in nature with limited follow-up. We compared these data with well-performed randomized controlled trials on thrombectomy. The retrospective studies may overestimate the effect size of outcomes and, as such, limit interpretation of pooled data. Many studies did not confirm their angiographic results with a core laboratory adjudicate, which may mean overestimation of outcome results. The durability of the outcomes and long-term complications could not be assessed, which limits provision of evidence-based guidelines and recommendations. Long-term follow-up and direct comparative studies in the future are required to determine whether the ADAPT approach can be a suitable alternative to standard endovascular therapy for acute ischemic stroke. The significant heterogeneity in outcomes may reflect varying degrees of technical experience with this new technology, and further studies may be required to document the learning curve associated with this technique. It is true that in many previous trials, there were likely unknown numbers of patients who underwent failed aspiration and went on to mechanical thrombectomy and possibly vice-versa. This heterogeneity is one of several reasons that first-generation trials failed. We exclude the possibility of such a confounding factor by only comparing ADAPT data to that of ESCAPE, EXTEND, MR CLEAN, REVASCAT, and SWIFT PRIME (ie, primary mechanical thrombectomy), and have now included this clarification in the manuscript text. Importantly, stent retriever thrombectomy remains the only tool studied with level 1 evidence and only randomized clinical trials can elevate aspiration thrombectomy to first-line therapy.
CONCLUSION
ADAPT represents an efficacious and cost-effective method for first-line acute ischemic stroke treatment, based on preliminary reports. The pooled results are comparable with recent randomized studies that demonstrate the benefit of endovascular therapy over intra-arterial medical therapy. Future direct comparative studies and randomized trials are required to confirm the benefit of the ADAPT strategy compared to standard endovascular therapy for acute ischemic stroke.
Disclosure
COMMENT
F
ollowing the results of MR CLEAN, 1 ESCAPE, 2 SWIFT PRIME, 3 EXTEND-IA, 4 and REVASCAT, 5 thrombectomy with stent retrievers (SR) has become standard of care for acute ischemic stroke patients presenting with ELVO within 6 hours. Based on the randomized nature of these studies, SR use remains the gold standard in stroke care, guiding the current treatment paradigm. Furthermore, new studies evaluating expansion of the time window, improvements in preprocedural imaging, and evolving techniques promise to continue to improve stroke care and broaden the patient population that may benefit. While use of SRs with concurrent aspiration is a variation of the established gold standard, the ADAPT technique is another shift from the established method in the 5 randomized controlled trials. Nonetheless, if aspiration is unsuccessful on 2 attempts, an SR is still utilized. Not only does this allow for potential cost savings and faster time to recanalization, a return to a more traditional method of thrombectomy with an SR is still advocated.
This meta-analysis comparing the ADAPT technique to traditional thrombectomy with SRs provides a pivotal first step in improving the technical aspects of revascularization. While SRs are still utilized in the event that aspiration was unsuccessful, 71.4% only required aspiration with equivocal clinical outcomes when compared to traditional techniques. Not only does this represent a significant cost saving, but decreases the time to recanalization, potentially ameliorating ischemic damage. Furthermore, while SRs may be the standard of care in thrombectomy, the damage to the endothelium following their use is significant, 6 and reducing this damage may play a large role in limiting
